Beneficial Effects of Amlodipine in a Murine Model of Congestive Heart Failure Induced by Viral Myocarditis
Authors:
- 7 January 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 95 (1) , 245-251
Abstract
BackgroundAlthough calcium channel blockers have not been shown to be beneficial for the treatment of patients with heart failure, a recent clinical trial demonstrated a favorable effect of amlodipine on the survival of patients with heart failure resulting from nonischemic dilated cardiomyopathy. We investigated the effects of amlodipine on a murine model of congestive heart failure induced by the M variant of encephalomyocarditis virus (EMCV).Methods and ResultsFour-week-old male DBA/2 mice were inoculated with EMCV and administered amlodipine, diltiazem, or vehicle PO for 2 weeks. The heart weight–to–body weight ratio and the histopathological grades of myocardial lesions were significantly lower and survival was significantly increased in the amlodipine-treated group (P<.01,P<.05, andP<.05, respectively) than in the control group. In vitro, amlodipine added to murine J774A.1 macrophages concomitant with EMCV inhibited nitrite formation in a concentration-dependent manner, but diltiazem did not. Furthermore,NG-monomethyl-l-arginine, an inhibitor of NO synthesis, decreased myocardial lesions significantly in this murine model. Immunohistochemistry revealed that the number of cells stained with antibody against an inducible NO synthase decreased significantly in the amlodipine-treated group compared with that in the control group (P<.01).ConclusionsAmlodipine appears to have a protective effect against myocardial injury in this animal model of congestive heart failure. The therapeutic effect of amlodipine may be in part resulting from inhibition of overproduction of NO.Keywords
This publication has 37 references indexed in Scilit:
- Increased circulating cytokines in patients with myocarditis and cardiomyopathy.Heart, 1994
- Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.Journal of Clinical Investigation, 1994
- Dihydropyridine Antagonists and Agonists of Calcium Channels Inhibit the Induction of Nitric Oxide Synthase by Endotoxin in Cultured MacrophagesBiochemical and Biophysical Research Communications, 1993
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Central and renal hemodynamic effects and hormonal response to diltiazem in severe congestive heart failureThe American Journal of Cardiology, 1987
- Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failureThe American Journal of Cardiology, 1985
- Sublingual nifedipine: Acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1985
- Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failureThe American Journal of Cardiology, 1984
- Hemodynamic effects of nifedipine in congestive heart failureThe American Journal of Cardiology, 1980